approved EB-1A

Staff Research Associate III

Medicinal Chemistry · India · 2023-01-24

Processing Time
145 days
Decision Date
2023-01-24
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner published 15 peer-reviewed articles in leading journals with a high cumulative impact factor.

Judging (Met)

The petitioner completed 92 peer reviews and served as an editor for 5 prestigious journals.

Original Contributions (Met)

The petitioner developed novel synthetic routes for drug compounds used in treating major diseases, evidenced by 233 citations.

Why This Petition Was Approved

The case was approved based on the petitioner's 15 peer-reviewed scientific articles with a cumulative impact factor of 69.504 and 233 citations from peers in 37 countries. He demonstrated extraordinary ability through 92 peer review assignments and editorial positions at 5 prestigious journals. His research provided practical applications for treating complex diseases like diabetes and tuberculosis.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
  • 15 peer-reviewed scientific articles in leading journals
  • 233 citations by peers in at least 37 countries
  • 92 peer review assignments for journals in the field
  • Editorial roles for 5 prestigious journals
  • Development of synthetic routes for drug compounds for diabetes, tuberculosis, and cancers
  • Cumulative impact factor of 69.504 for published work

Similar Cases

Associate Professor

Pharmaceuticals · China

WeGreened EB-1A approved
70 days 2022-05-24
The petition was approved based on 43 peer-reviewed articles, 2 book chapters, and 6 patents which garnered 362 citations from researchers in 35 countries. Additionally, the petitioner demonstrated extraordinary ability through a significant record of 70 peer review assignments for professional journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Assistant Professor

Pharmaceuticals · India

WeGreened EB-1A rfe approved
Texas 558 days 2025-09-08
The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.

Postdoctoral Researcher

Pharmaceuticals · India

WeGreened EB-1A approved
North Carolina 18 days 2025-04-24
The petition was approved based on the authorship of 52 peer-reviewed journal articles and a massive citation count of 7,116, placing the petitioner in the top 1% of the field. Additionally, the petitioner demonstrated significant peer recognition through over 200 journal reviews and editorial board service. The evidence satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Others

Pharmaceuticals · China

WeGreened EB-1A approved
Arkansas 197 days 2023-02-21
The petition was approved based on a Ph.D. in medicinal chemistry and a record of 20 peer-reviewed scientific articles and 3 patent applications. His work garnered 237 citations from researchers in at least 33 countries, demonstrating sustained international acclaim. Additionally, he satisfied the judging criterion by conducting at least 20 manuscript reviews for highly discerning journals.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 145 days
Criteria Met 3 / 3
Evidence Types 5

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist